{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:13:38Z","timestamp":1783685618805,"version":"3.55.0"},"reference-count":57,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["Policy Research Programme (NIHR205435)"],"award-info":[{"award-number":["Policy Research Programme (NIHR205435)"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Stem cell transplant (SCT) is a potential cure for haematological malignancies whose outcomes are predicted to be poor on chemotherapy alone and cases difficult to treat using standard of care treatment. There is growing evidence to show that not all patients who would benefit from SCT receive it due to inequities in the treatment pathway. The role of socioeconomic deprivation on inequities in the SCT setting is unclear due to conflicting findings. We aim to synthesise the UK evidence base in this area from the point of diagnosis to transplant to guide further research and policy to improve survival for underserved patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and analysis<\/jats:title>\n                    <jats:p>Primary electronic searches will be performed in bibliographic databases including MEDLINE, Embase, Proquest Databases, Central &amp; CDSR, Stem Cell Evidence and Web of Science and Google Scholar for grey literature. Eligibility criteria will include observational studies of UK patients diagnosed with haematological malignancies treated with SCT, where outcomes are reported according to socioeconomic deprivation. Two independent reviewers will screen each study and assess the quality of all included studies using the Newcastle-Ottawa grading system. Outcomes of interest include delay in diagnosis\/referral, treatments\/interventions received, referral to transplant, presence of comorbidities affecting transplant eligibility, transplant utilisation rates, waiting time to transplant and survival rates. Post-transplant outcomes are beyond the scope of this review. Inequities in SCT due to socioeconomic deprivation will be narratively summarised. Meta-analysis will be conducted dependent on data availability. This protocol has been registered with PROSPERO (2024: CRD42024620592).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not required for this study as it is a secondary analysis of published data.<\/jats:p>\n                    <jats:p>We are not aware of any ethical concerns regarding SCT or treatment of donors in the studies included in this research. This systematic review will retrieve, screen and extract data from UK research. SCT and the treatment of donors in the UK follow the National Health Service (NHS) and NHS Blood and Transplant guidelines and policies and are regulated by the Human Tissue Authority and Medicines and Healthcare Products Regulatory Agency. The data which will be used in this review will consist of data from NHS digital\/NHS England or single NHS centre data, which will follow the guidelines and regulations above.<\/jats:p>\n                    <jats:p>The findings will be submitted for peer-reviewed publication, shared at conference presentations, and disseminated to both clinical and patient groups including National (Black, Asian, Mixed Race and Minority Ethnic) BAME Transplant Alliance and the National Institute for Health Research Blood and Transplant Research Unit in Precision Transplant and Cellular Therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42024620592.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-111282","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:20:12Z","timestamp":1783682412000},"page":"e111282","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Role of socioeconomic deprivation on inequities in care outcomes of haematological malignancies treated with stem cell transplant in the UK: a systematic review protocol"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4366-8344","authenticated-orcid":false,"given":"Zareen","family":"Deplano","sequence":"first","affiliation":[{"name":"Department of Applied Health Sciences, University of Birmingham, Birmingham, UK"},{"name":"Cell, Apheresis & Gene Therapies, NHS Blood and Transplant, Bristol, UK"},{"name":"Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, NIHR, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2904-5102","authenticated-orcid":false,"given":"Samuel","family":"Cusworth","sequence":"additional","affiliation":[{"name":"Department of Applied Health Sciences, University of Birmingham, Birmingham, UK"},{"name":"Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, NIHR, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"Systematic Review Initiative, NHS Blood and Transplant, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Griffin","sequence":"additional","affiliation":[{"name":"Cell, Apheresis & Gene Therapies, NHS Blood and Transplant, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0543-3254","authenticated-orcid":false,"given":"Nicola","family":"Adderley","sequence":"additional","affiliation":[{"name":"Department of Applied Health Sciences, University of Birmingham, Birmingham, UK"},{"name":"Birmingham Biomedical Research Centre, National Institute for Health and Care Research, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joht Singh","family":"Chandan","sequence":"additional","affiliation":[{"name":"Department of Applied Health Sciences, University of Birmingham, Birmingham, UK"},{"name":"Birmingham Biomedical Research Centre, National Institute for Health and Care Research, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026071004200773000_16.7.e111282.1","unstructured":"Haematological Malignancy Research Network (HMRN) . HMRN - haematological malignancies. HMRN; 2017. Available: https:\/\/hmrn.org\/about\/classification"},{"key":"2026071004200773000_16.7.e111282.2","doi-asserted-by":"crossref","unstructured":"Jurlander J . Hematological malignancies, leukemias and lymphomas. In: Encyclopedia of cancer. 2008: 1328\u201332. Available: https:\/\/link.springer.com\/rwe\/10.1007\/978-3-540-47648-1_2615","DOI":"10.1007\/978-3-540-47648-1_2615"},{"key":"2026071004200773000_16.7.e111282.3","unstructured":"ONS . Cancer registration statistics, England - Office for National Statistics. ONS; 2024. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancerregistrationstatisticsengland\/2017"},{"key":"2026071004200773000_16.7.e111282.4","unstructured":"Blood Cancer UK . Blood cancer facts. Blood Cancer UK; 2024. Available: https:\/\/bloodcancer.org.uk\/news\/blood-cancer-facts\/"},{"key":"2026071004200773000_16.7.e111282.5","unstructured":"National Disease Registration Service . Get data out. NHS England; 2023. Available: https:\/\/nhsd-ndrs.shinyapps.io\/get_data_out\/"},{"key":"2026071004200773000_16.7.e111282.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659595","article-title":"Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?","volume":"12","author":"Loke","year":"2021","journal-title":"Front Immunol"},{"key":"2026071004200773000_16.7.e111282.7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2020-137575","article-title":"Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02\/HO95 Study","volume":"136","author":"Cavo","year":"2020","journal-title":"Blood"},{"key":"2026071004200773000_16.7.e111282.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.813"},{"key":"2026071004200773000_16.7.e111282.9","unstructured":"BSBMTCT . Activity report 2023. BSBMTCT. British Society of Blood and Marrow Transplantation; 2023. Available: https:\/\/bsbmtct.org\/activity\/2023\/"},{"key":"2026071004200773000_16.7.e111282.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6499"},{"key":"2026071004200773000_16.7.e111282.11","unstructured":"Office for National Statistics . Healthy life expectancy by national area deprivation, England and Wales - Office for National Statistics. 2025. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthinequalities\/bulletins\/healthylifeexpectancybynationalareadeprivationenglandandwales\/between2013to2015and2020to2022"},{"key":"2026071004200773000_16.7.e111282.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.r367","article-title":"Cancer: people in UK\u2019s poorest areas have longer waits for care and higher death rates","volume":"388","author":"O\u2019Dowd","year":"2025","journal-title":"BMJ"},{"key":"2026071004200773000_16.7.e111282.13","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","article-title":"Differences in cancer incidence by broad ethnic group in England, 2013\u20132017","volume":"126","author":"Delon","year":"2022","journal-title":"Br J Cancer"},{"key":"2026071004200773000_16.7.e111282.14","unstructured":"Blood Cancer UK . Taking blood cancer out of the shadows: a plan to increase survival in the UK. Blood Cancer UK; 2024. Available: https:\/\/bloodcancer.org.uk\/news\/uk-blood-cancer-action-plan-launched"},{"key":"2026071004200773000_16.7.e111282.15","unstructured":"Anthony Nolan, The Secretariat to the APPG on Stem Cell Transplantation . No patient left behind: the barriers stem cell transplant patients face when accessing treatment and care. London: Anthony Nolan; 2021. Available: https:\/\/www.anthonynolan.org\/sites\/default\/files\/2021-05\/no_patient_left_behind_final.pdf"},{"key":"2026071004200773000_16.7.e111282.16","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X705473"},{"key":"2026071004200773000_16.7.e111282.17","unstructured":"Hicks S , McGarry N . Blood cancer patient experience for Black, Asian and ethnic minority patients. ClearView Research; 2022. Available: https:\/\/static1.squarespace.com\/static\/5b98cdc612b13fdd2982129d\/t\/6387561da2a03105934f1bad\/1669813794902\/Blood+Cancer+Patient+Experience+for+Black%2C+Asian+and+Ethnic+Minority+Patients.pdf"},{"key":"2026071004200773000_16.7.e111282.18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/bjc.2012.171","article-title":"Reply: \u2018Childhood leukaemia and socioeconomic status\u2019","volume":"107","author":"Kroll","year":"2012","journal-title":"Br J Cancer"},{"key":"2026071004200773000_16.7.e111282.19","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.415"},{"key":"2026071004200773000_16.7.e111282.20","first-page":"1566","article-title":"Social deprivation independently impacts clinical outcomes in patients with chronic lymphocytic leukemia","volume":"109","author":"Fegan","year":"2024","journal-title":"Haematologica"},{"key":"2026071004200773000_16.7.e111282.21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-252","article-title":"The incidence of and mortality from leukaemias in the UK: a general population-based study","volume":"9","author":"Bhayat","year":"2009","journal-title":"BMC Cancer"},{"key":"2026071004200773000_16.7.e111282.22","doi-asserted-by":"crossref","first-page":"101321","DOI":"10.1016\/j.beha.2021.101321","article-title":"Since everyone has a donor, why are some eligible patients still not transplanted?","volume":"34","author":"Eapen","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"key":"2026071004200773000_16.7.e111282.23","unstructured":"Mack J . Deprivation and poverty | poverty and social exclusion. UKRI Economic and Social Research Council; 2016. Available: https:\/\/www.poverty.ac.uk\/definitions-poverty\/deprivation-and-poverty"},{"key":"2026071004200773000_16.7.e111282.24","unstructured":"Ministry of Housing, Communities & Local Government . English indices of deprivation 2019: research report. GOV.UK; 2019. Available: https:\/\/www.gov.uk\/government\/publications\/english-indices-of-deprivation-2019-research-report"},{"key":"2026071004200773000_16.7.e111282.25","unstructured":"NHS England . The NHS long term plan. NHS; 2019. Available: https:\/\/www.longtermplan.nhs.uk"},{"key":"2026071004200773000_16.7.e111282.26","unstructured":"NHS England . Core20PLUS5 \u2013 an approach to reducing health inequalities for children and young people. 2024. Available: https:\/\/www.england.nhs.uk\/about\/equality\/equality-hub\/national-healthcare-inequalities-improvement-programme\/core20plus5\/core20plus5-cyp\/"},{"key":"2026071004200773000_16.7.e111282.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.07.023"},{"key":"2026071004200773000_16.7.e111282.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006252"},{"key":"2026071004200773000_16.7.e111282.29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s40615-023-01611-8","article-title":"Evaluating Socioeconomic, Racial, and Ethnic Disparities in Survival Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplants","volume":"11","author":"Garcia","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"key":"2026071004200773000_16.7.e111282.30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41375-024-02172-3","article-title":"Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"38","author":"Olivieri","year":"2024","journal-title":"Leukemia"},{"key":"2026071004200773000_16.7.e111282.31","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026071004200773000_16.7.e111282.32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41409-018-0105-9","article-title":"Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: A National Cancer Database Study","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"2026071004200773000_16.7.e111282.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS ONE"},{"key":"2026071004200773000_16.7.e111282.34","unstructured":"Cradock C , Miflin G , UK Stem Cell Strategic Forum . 10 year strategy for stem cell transplantation and cellular therapies. NHS Blood and Transplant; 2022. Available: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/28283\/a-10-year-vision-for-hsct-and-cellular-therapies-august-2022-8.pdf"},{"key":"2026071004200773000_16.7.e111282.35","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.2138.2138","article-title":"Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants","volume":"122","author":"Lown","year":"2013","journal-title":"Blood"},{"key":"2026071004200773000_16.7.e111282.36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bmt.2012.54","article-title":"Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision","volume":"48","author":"Lown","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2026071004200773000_16.7.e111282.37","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2352-3026(24)00316-8","article-title":"Health inequity has no boundaries","volume":"11","author":"Auletta","year":"2024","journal-title":"Lancet Haematol"},{"key":"2026071004200773000_16.7.e111282.38","doi-asserted-by":"crossref","unstructured":"Coates MJ , Bhardwaj SA , Igwe R , et al . The Relationship Between Ethnicity and Socioeconomic Deprivation as Determinants of Health: A Systematic Review. Epidemiol Public Health 2024;2. doi:10.52768\/EpidemiolPublicHealth\/1030","DOI":"10.52768\/EpidemiolPublicHealth\/1030"},{"key":"2026071004200773000_16.7.e111282.39","unstructured":"GOV.UK . People living in deprived neighbourhoods - GOV.UK Ethnicity facts and figures. 2020. Available: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/uk-population-by-ethnicity\/demographics\/people-living-in-deprived-neighbourhoods\/latest\/"},{"key":"2026071004200773000_16.7.e111282.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-099354","article-title":"Protocol: what are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant\/cellular therapies, in the UK? A systematic review","volume":"15","author":"Cusworth","year":"2025","journal-title":"BMJ Open"},{"key":"2026071004200773000_16.7.e111282.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026071004200773000_16.7.e111282.42","unstructured":"Cochrane . Cochrane handbook for systematic reviews of interventions. Cochrane Training, Available: https:\/\/training.cochrane.org\/handbook\/current"},{"key":"2026071004200773000_16.7.e111282.43","doi-asserted-by":"crossref","unstructured":"Moher D , Shamseer L , Clarke M , et al . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4. doi:10.1186\/2046-4053-4-1","DOI":"10.1186\/2046-4053-4-1"},{"key":"2026071004200773000_16.7.e111282.44","unstructured":"Clinical Practice Research Datalink (CPRD) . Small area level data based on patient postcode. London: Medicines and Healthcare Products Regulatory Agency; 2024. Available: https:\/\/www.cprd.com\/data\/linked-data\/small-area-level-data"},{"key":"2026071004200773000_16.7.e111282.45","unstructured":"British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT) . HSCT adult indications. London: BSBMTCT; 2023. Available: https:\/\/bsbmtct.org\/indications-sub-committee\/"},{"key":"2026071004200773000_16.7.e111282.46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jrsm.1275","article-title":"A review of the reporting of web searching to identify studies for Cochrane systematic reviews","volume":"9","author":"Briscoe","year":"2018","journal-title":"Res Synth Methods"},{"key":"2026071004200773000_16.7.e111282.47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138237","article-title":"The Role of Google Scholar in Evidence Reviews and Its Applicability to Grey Literature Searching","volume":"10","author":"Haddaway","year":"2015","journal-title":"PLoS One"},{"key":"2026071004200773000_16.7.e111282.48","unstructured":"Covidence . Covidence - better systematic review management. 2024. Available: https:\/\/www.covidence.org\/"},{"key":"2026071004200773000_16.7.e111282.49","unstructured":"Elsevier . Mendeley reference manager. 2024. Available: https:\/\/www.mendeley.com"},{"key":"2026071004200773000_16.7.e111282.50","unstructured":"Page MJ , McKenzie JE , Bossuyt PM , et al . PRISMA 2020 flow diagram for new systematic reviews. PRISMA Statement; 2021. Available: https:\/\/www.prisma-statement.org\/prisma-2020-flow-diagram"},{"key":"2026071004200773000_16.7.e111282.51","unstructured":"Cochrane . Chapter 4: searching for and selecting studies | Cochrane training. Cochrane, Available: https:\/\/training.cochrane.org\/handbook\/current\/chapter-04"},{"key":"2026071004200773000_16.7.e111282.52","unstructured":"Wells G , Wells G , Shea B , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute: Ottawa; 2014. Available: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"2026071004200773000_16.7.e111282.53","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"Available from","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026071004200773000_16.7.e111282.54","doi-asserted-by":"crossref","unstructured":"Carra MC , Romandini P , Romandini M . Risk of Bias Evaluation of Cross\u2010Sectional Studies: Adaptation of the Newcastle\u2010Ottawa Scale. J Periodontal Res 2025. doi:10.1111\/jre.13405","DOI":"10.1111\/jre.13405"},{"key":"2026071004200773000_16.7.e111282.55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"2026071004200773000_16.7.e111282.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2026071004200773000_16.7.e111282.57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-111282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:20:20Z","timestamp":1783682420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-111282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,10]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2025-111282"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-111282","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}